FDA Limits Use of Regeneron, Lilly COVID-19 Antibody Treatments
The U.S. health regulator on Monday revised the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli Lilly to limit their use, as the drugs are unlikely to work against the omicron variant.The Food and Drug Administratio…